HEMOSTAT
Dead / Abandoned — Abandoned — failure to respond (as of 07 Apr 2025)
What this means for you
This application is over — abandoned 20 Mar 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98587896
- Mark type
- Stylized text
- Filed
- 06 Jun 2024
- Abandoned
- 20 Mar 2025
- Attorney of record
- Katherine P. Califa
Goods and services
- Class 005 — Pharmaceuticals: Biological tissue grafts; absorbable powder particles for use as a surgical wound dressing; biomaterial surgical sealants; surgical implants comprising living tissues; Chemical preparations for medical purposes, namely, for improving blood coagulation and supporting natural blood cascade during surgical procedures and emergency treatments
- Class 010 — Medical apparatus: Surgical implants comprising artificial material with a blood clotting coating; medical devices for administering absorbable powder particles for use as a surgical wound dressing and surgical implants comprising artificial material with a blood clotting coating
Owner
- Zetagen Therapeutics, Inc., Syracuse, NY, US
Prosecution history
- 07 Apr 2025 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 07 Apr 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 19 Dec 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 19 Dec 2024 — NON-FINAL ACTION E-MAILED
- 19 Dec 2024 — NON-FINAL ACTION WRITTEN
- 19 Dec 2024 — ASSIGNED TO EXAMINER
- 18 Dec 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 06 Jun 2024 — NEW APPLICATION ENTERED